# Daily Brief - January 07, 2026

---

## Global Markets

| Category | Item | Price/Rate | Yield | Daily Î”% |
|:---------|:-----|----------:|------:|---------:|
| Index Futures | S&P 500 | 6,986.00 | - | -0.03% |
|  | NASDAQ | 25,771.75 | - | -0.19% |
|  | Russell 2000 | 2,598.80 | - | +0.09% |
|  | Nikkei 225 | 51,980.00 | - | -0.12% |
| Fixed Income | US 30Y | - | 4.81% | -1.17% |
|  | US 10Y | - | 4.12% | -1.32% |
|  | US 2Y | - | 3.52% | -0.14% |
|  | US 3M | - | 3.52% | -0.14% |
| Commodities | WTI Crude | $56.82 | - | -0.54% |
|  | Gold | $4,452.80 | - | -0.96% |
|  | Copper | $5.95 | - | -1.94% |
|  | Lumber | $532.00 | - | +0.00% |

| Category | Item | Price/Rate | Daily Î”% |
|:---------|:-----|----------:|---------:|
| Foreign Exchange | EUR/USD | 1.1693 | +0.04% |
|  | USD/JPY | 156.3950 | -0.14% |
|  | USD/CNY | 6.9961 | +0.18% |
| Crypto Currencies | Bitcoin | $92,025.99 | -1.79% |
|  | Ethereum | $3,210.66 | -2.57% |
|  | Solana | $138.03 | -2.17% |
|  | Sui | $1.89 | -0.91% |

---

## Sector Performance

```
Healthcare           +â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                 +2.72%
Industrials          +â–ˆâ–ˆâ–ˆâ–ˆ                  +2.20%
Real Estate          +â–ˆâ–ˆâ–ˆ                   +1.67%
Consumer Defensive   +â–ˆâ–ˆ                    +1.33%
Basic Materials      +â–ˆ                     +0.88%
Consumer Cyclical    +                      +0.48%
Technology           +                      +0.35%
Financial Services   +                      +0.15%
Communication Servic                      - -0.48%
Utilities                                â–ˆ- -0.65%
Energy                                  â–ˆâ–ˆ- -1.38%
```

| Sector | Change |
|:-------|-------:|
| Healthcare | +2.72% |
| Industrials | +2.20% |
| Real Estate | +1.67% |
| Consumer Defensive | +1.33% |
| Basic Materials | +0.88% |
| Consumer Cyclical | +0.48% |
| Technology | +0.35% |
| Financial Services | +0.15% |
| Communication Services | -0.48% |
| Utilities | -0.65% |
| Energy | -1.38% |

---

## Summary
Total updates received: 13 items

### Market-Moving News

â€¢ **M&A Announcements**: Multiple notable mergers and acquisitions were announced, including First Mid Bancshares acquiring Two Rivers Financial Group, QNB Corp merging with The Victory Bancorp, and Waters Corp striking a deal with Becton, Dickinson and Company.

â€¢ **Investor Interest in M&A**: Comerica's shareholders approved a $10.9 billion merger with Fifth Third Bancorp, illustrating continued robust activity in the M&A sector.

â€¢ **Pre-Market Movers**: Key pre-market stock gainers include Crinetics Pharmaceuticals (CRNX), up 5.12%, driven by positive investor sentiment regarding upcoming trial results, and CoStar Group (CSGP), climbing 4.20%, likely influenced by an upbeat earnings forecast.

â€¢ **Market Trends**: Economic data released shows U.S. private payrolls rose by 41,000 in December, which is below expectations but reflects a steady job market, influencing pre-market sentiments moderately.

â€¢ **Economic Outlook**: Analysts suggest rate cuts could positively impact equities in the upcoming quarters, amidst cautious optimism regarding further M&A activity.

â€¢ **Significant Company Developments**: Amgen announced the acquisition of Dark Blue Therapeutics for $840 million, enhancing its oncology portfolio, while Merck is set to finalize its acquisition of Cidara Therapeutics, signifying ongoing consolidation in the biotech sector. 

â€¢ **Cybersecurity Deals**: The Cybersecurity sector is heating up, as various acquisitions signal growth potential, reflecting heightened investor

---

## Pre-Market Movers

**Top Gainers:** CRNX +5.12% | CSGP +4.20% | MSTR +3.70% | IRM +2.36% | TT +2.32% | REGN +2.12% | ALB +2.12% | TPR +2.11% | RJF +2.01% | SYF +1.76%

**Top Losers:** FSLR -4.68% | DECK -3.61% | NEM -3.08% | FCX -2.32% | STX -1.85% | CCL -1.80% | AMAT -1.76% | LRCX -1.62% | NXPI -1.50% | ACN -0.11%

---

## Disruption/Innovation Index News

â€¢ **AAOI**: Insider David Kuo sells 12,500 shares as the stock declines 5.9%, signaling potential concerns about the company's near-term outlook.  
â€¢ **AAON**: Copeland Capital Management invests $68 million in AAON, indicating strong institutional confidence in the companyâ€™s growth potential.  
â€¢ **ABNB**: Brokerages assign Airbnb an average rating of "Hold," reflecting cautious sentiment amid market turbulence impacting its share performance.  
â€¢ **ADBE**: First Merchants Corp reduces its position in Adobe, which may suggest a bearish outlook among institutional investors regarding Adobe's near-term performance.  
â€¢ **BIDU**: Significant development as Baidu's AI chip unit plans an IPO, reinforcing its commitment to expanding AI capabilities and potentially unlocking new revenue streams.  
â€¢ **TSLA**: Downgraded by GLJ Research from Sell to Sell, indicating continued bearish sentiment around Tesla's stock performance.  
â€¢ **ASTS**: Downgraded by Scotiabank from Sector Perform to Underperform, reflecting diminished expectations for the companyâ€™s near-term growth.

---

## IBD Market Prep

### Dow Dips But Nvidia Rallies On New AI Chip; Tesla Regains Key Level
*Received: Tue, 06 Jan 2026 07:35:16 -0600*

- **Market Overview**: The Dow Jones index experienced a decline, while Nvidia shares surged on the announcement of a new AI chip. Additionally, Tesla regained a significant price level, suggesting potential recovery.

- **Key Financial Developments**: Truist Securities initiated coverage on Palantir with a "Buy" rating, indicating optimism for the stock, which is positioned within the AI sector. In a notable strategic move, Accenture acquired the AI firm Faculty, a direct competitor to Palantir.

- **Investment Insights**: Vistra made headlines with a $4 billion investment in natural gas power generation, acquiring 5.5 gigawatts of capacity, reflecting a bullish stance on energy expansion. 

- **Emerging Trends**: Quantum computing stocks are showing positive performance early in 2026, with significant advancements expected. Notable companies like Nvidia and Solaris have been added to multiple "best stock" lists, indicating strong market sentiment around AI and tech-driven investments.

---

### The Big Picture: Growth Stocks Lead Market Higher For Second Day As S&P 500 Hits Record
*Received: Tue, 06 Jan 2026 17:49:14 -0600*

- **Market Performance**: Growth stocks led market gains for the second consecutive day as the S&P 500 reached a new closing record high. This indicates positive momentum in the overall market sentiment.

- **Key Stock Movements**: Seagate's stock is seeing a breakout following a remarkable 219% rally in 2025. Additionally, Nvidiaâ€™s stock surged 35% after announcing a new LiDAR supplier for its self-driving technology. In biotech, Alumis shares rose over 95% due to promising psoriasis treatment results.

- **Emerging Trends**: Morgan Stanley has filed for a Bitcoin ETF amid Bitcoin prices stabilizing near $94,000, while Goldman Sachs identified top cryptocurrency investment opportunities for 2026. Rare earth stocks are also experiencing a revival due to geopolitical tensions.

- **Actionable Insights**: Investors may look to consider growth stocks, particularly in AI and biotech, as they show strong short-term potential. Keeping an eye on crypto developments and tech stocks like Microsoft, which is positioned well in the AI race, could provide further investment opportunities.

---

## Investor's Business Daily

### Make this your strongest trading year yetâ€”take $600 off MarketSurge ðŸ™Œ
*Received: Tue, 06 Jan 2026 13:01:45 -0600*

- **Promotion of MarketSurge:** Investor's Business Daily is offering a $600 discount for a 14-month subscription to MarketSurge, valued at $2,099, as part of their New Year's Sale. This promotion aims to help investors build a consistent trading routine.

- **Features of MarketSurge:** The platform provides access to the Growth 250 list of high-potential stocks, extensive databases of over 18,000 stocks, ETFs, and mutual funds, and advanced charting tools including AI-powered Pattern Recognition to identify buy points and sell signals.

- **Actionable Insight:** Investors looking to enhance their portfolios in 2026 are encouraged to take advantage of the limited-time discount and utilize MarketSurgeâ€™s resources for optimal stock research and trading efficiency.

- **Call to Action:** Interested individuals should act quickly to secure the offer before it expires, which can be found via the provided link.

---

## IBD Tech Report

### A Serious Challenge To Lillyâ€™s Zepbound?
*Received: Tue, 06 Jan 2026 16:03:10 -0600*

- **Biotech Developments**: Arrowhead Pharmaceuticals reported a significant breakthrough, with its gene-silencing technology nearly doubling the weight loss achieved with Eli Lilly's tirzepatide, leading to an 11% stock increase for Arrowhead.

- **Stock Ratings and Acquisitions**: Truist Securities initiated coverage of Palantir with a "buy" rating, while Accenture acquired AI startup Faculty, a competitor to Palantir, enhancing its capabilities in the AI sector.

- **Market Performance**: The Dow and S&P 500 reached record highs, while Nvidia's stock rose amidst a sell-off in other AI-related stocks, reflecting ongoing investor interest in AI.

- **Other Notable Stocks**: Seagate's stock is breaking out after a successful rally in 2025, and Alumis saw a remarkable 95% jump in stock price after releasing positive data for psoriasis treatment, positioning it as a competitor to Johnson & Johnson. 

These developments suggest a volatile but promising landscape for biotech and tech stocks, with potential actionable insights for investors considering entry points into these high-growth areas.

---

## Endpoints | Pharma

### Childhood vaccine overhaul sets up Gardasil dosing debate
*Received: Wed, 07 Jan 2026 08:27:49 +1100*

- **Key Headlines**: The newsletter discusses the recent overhaul of the childhood vaccine schedule, notably raising debates over Gardasil's dosing. Additionally, Jazz and Zymeworks report a significant HER2 bispecific win for advanced stomach cancer treatment.

- **Important Developments**: The FDA missed its deadline for a report linking COVID vaccines to childrenâ€™s deaths, while Johnson & Johnson plans a late-stage trial for a lupus candidate following promising Phase 2 results. Moreover, Amgen is set to acquire Dark Blue Therapeutics for up to $840 million, indicating continued interest in oncology-related innovations.

- **Actionable Insights**: Investors should monitor developments surrounding the Gardasil dosing debate, as vaccine regulations could impact pharmaceutical companies involved. Engagements like Lillyâ€™s $55 million deal with Nimbus for an oral obesity drug point to opportunities in the burgeoning obesity market.

---

## The Barron's Daily

### Trumpâ€™s Venezuela Action Is Boosting Oil Stocks. Why the Raid Was the Easy Part.
*Received: Tue, 06 Jan 2026 22:51:33 +1100*

- **Venezuela Oil Market Reaction**: U.S. military action in Venezuela has led to a 5% rise in Chevron's stock, reflecting investor optimism about potential access to Venezuela's vast oil reserves. However, experts caution that significant investment and production increases are unlikely in the short term.

- **Investment Concerns**: U.S. oil majors, including Chevron, Exxon Mobil, and ConocoPhillips, may be hesitant to make major commitments due to past nationalization risks and the estimated $53 billion cost over 15 years needed to maintain current production levels.

- **Market Insights**: A limited uptick in Venezuelan production could benefit Gulf Coast refiners like Valero Energy, while oil services firms such as SLB and Halliburton may be disappointed if investments fall short of expectations, as indicated by current crude pricing trends.

- **Nvidia Update**: Nvidia's CEO announced the full production of their latest AI chip, Vera Rubin, at CES, signaling continued advancements in the tech sector alongside the oil market developments.

---

### Sandisk Replaces Nvidia as the New AI Chip Darling. Why Thatâ€™s a Big Risk.
*Received: Wed, 07 Jan 2026 23:08:31 +1100*

- **Market Shift**: Sandisk has emerged as a leading AI chip company, overtaking Nvidia, which may pose risks for investors as the memory-chip market can be volatile and cyclical. 
- **Stock Movements**: Sandisk recently experienced a 27% stock price increase, driven by investors reacting to Nvidia CEO Jensen Huang's comments about rising demand for memory products; however, retail trading patterns suggest herd behavior.
- **Demand Forecast**: Counterpoint Research predicts a 40%-50% surge in memory prices this quarter due to heightened demand for AI and server capacity, which could lead to increased costs for smartphones and laptops, potentially impacting major tech companies like Apple and Dell.
- **Investment Caution**: While the adage "sell shovels in a gold rush" applies, investors are advised to proceed with caution in the memory sector, given the competitive landscape and uncertain market shares, particularly with Chinese rival Yangtze Memory Technologies gaining ground.

---

## BioPharmCatalyst

### Daily Updates: Alumis ALMS +95% Phase 3 Data; Ventyx VTYX +55% AH M&A Talks Eli Lilly LLY
*Received: Tue, 06 Jan 2026 23:12:22 +0000*

- **Key Developments**: Alumis Inc. (ALMS) shares surged 95% to $16.23 following positive Phase 3 trial results for its TYK2 inhibitor, envudeucitinib, for psoriasis, achieving significant efficacy (p < 0.0001). Ventyx Biosciences (VTYX) saw a 55% increase to $15.55 on reports of advanced acquisition talks with Eli Lilly (LLY).

- **Other Notable Movements**: Cyclerion Therapeutics (CYCN) shares climbed 41% to $1.95 after announcing a partnership to enhance its treatment-resistant depression therapy. Acrivon Therapeutics (ACRV) gained 31%, closing at $3.01, ahead of a significant data update scheduled for January 2026. In contrast, Instil Bio (TIL) dropped 46% to $6.66 due to the discontinuation of a developmental candidate.

- **Actionable Insights**: Investors should monitor Ventyx as a potential acquisition play and consider positions in Alumis for growth, given its promising trial results. Caution is advised with Instil Bio, as its abandonment of AXN-2510 may indicate underlying challenges.

---

## Erik@YWR

### YWR: Who am I Sector?
*Received: Tue, 6 Jan 2026 08:22:24 +0000*

- **Investment Insight**: The newsletter highlights Chinese banks as undervalued investment opportunities, trading at a 55% discount relative to global peers despite similar capital ratios, returns on equity, and asset quality metrics. 

- **Key Performance Data**: Chinese banks reported a 30% increase in 2025 with current dividends yielding around 6%. The China 10-year bond yield stands at just 1.85%, prompting a favorable risk-reward scenario for investors in large-cap banks.

- **Market Context**: With ongoing government stimulation and record low interest rates, there is optimism that the Chinese banking sector can replicate the positive trajectory witnessed in the U.S. during its 2010 recovery phase.

- **Recommendation**: Investors are advised to consider the attractive valuation of Chinese banks, backed by stable depositors and a diversified asset base, particularly given potential macroeconomic recovery as property sector concerns begin to ease.

---

## Dave Lutz (JONESTRADING INSTITU)

### What I am Chattering about as the Sprinklers rain on Key Royale.
*Received: Tue, 6 Jan 2026 11:00:52 -0000*

- **Market Overview**: Futures are mixed with QQQs slightly up due to advancements from NVDA and AMD, while MCHP saw a notable 4% increase. The Russell is down 30 basis points, though bank stocks are experiencing a breakout, anticipating JPM's earnings next week. The DAX and FTSE are up modestly, driven by healthcare and energy sectors.

- **Economic Indicators & Expectations**: Key economic releases include the S&P Global US Services PMI and insights from Fed officials Barkin and Miran. Treasury yields are approaching multi-month highs with the US dollar showing signs of recovery.

- **Commodity Movements**: Nickel surged 6%, with other metals like Zinc and Silver recording gains. Conversely, natural gas is down 2.5%. WTI crude oil is up 50 basis points amid expectations of supply news from Venezuela.

- **Recommendations**: Monitor the performance of retail sales data and Fed speeches for insights on economic direction. Keep an eye on commodity trends, particularly in metals and energy, for potential trading opportunities.

---

### WHAT TRADERS ARE WATCHING THIS TUESDAY MORNING
*Received: Tue, 6 Jan 2026 13:45:00 -0000*

- **Key Updates**: Nvidia begins production of its new data center processors, while AMD announces a new chip aimed at challenging Nvidia in the AI hardware market. The Semiconductor ETF (SMH) has reached an all-time high, with the QQQs expected to follow.

- **Financial Sector Rally**: Financial stocks outperformed broader market gains on Monday, driven by a sector rotation from tech and a steeper yield curve. Analysts suggest this is a favorable time to take profits in tech and invest in undervalued financials ahead of upcoming bank earnings.

- **Market Highlights**: Caterpillar's CEO discusses innovations at the CES trade show, emphasizing trends in autonomous driving technology. Meanwhile, JPMorgan is optimistic about a robust M&A and IPO pipeline despite global uncertainties.

- **Market Trends**: The Dow recently recorded its strongest "Santa Claus Rally" in four years, while the S&P 500 is experiencing a historic three-day losing streak, highlighting divergence in index performances. Traders should monitor developments regarding Fed leadership and continued earnings results as potential market catalysts.

---

### What I am Chattering about as the Sun rises over Hurricane Hanks
*Received: Wed, 7 Jan 2026 12:24:56 -0000*

- **Market Overview**: U.S. futures are slightly drifting, with Russell outperforming Nasdaq by 30 basis points. S&P is retreating from all-time highs amid confirmations of Dow Theory, while MSTR surged after MSCI's decision regarding crypto treasury companies.

- **International Markets**: Mixed trading in Europe; DAX up 60 bps due to strong economic data, while FTSE down 60 bps as commodities decline. In Asia, Nikkei lost 1% influenced by Chinese curbs; however, KOSPI gained 60 bps driven by Samsung and Hynix.

- **Bond Market Activity**: A surge into sovereign bonds emerged following weaker EU inflation, influencing ECB easing expectations. U.S. treasuries saw a decline in yields, with the 10-year down 3 bps.

- **Upcoming Data Releases**: Key economic indicators anticipated today include ADP Employment Change, ISM Services Index, and JOLTS Job Openings. Investors should remain vigilant for potential market impacts from these reports and the upcoming DOE data on energy inventories.

---

### WHAT TRADERS ARE WATCHING AS THE MARKET SETS UP FOR A "PAIN TRADE"
*Received: Wed, 7 Jan 2026 13:23:38 -0000*

- **Market Movements & Trends**: January marks a significant allocation window as capital moves from cash into passive risk assets driven by declining money market yields. The short interest of the median S&P 500 stock is high, indicating a potential squeeze as financial conditions improve with expectations of fiscal and monetary stimulus.

- **Dow Theory Signal**: Both the DJIA and DJTA indicated a primary trend signal, suggesting continued economic growth as both indices move in the same direction.

- **Earnings & Stock Highlights**: Banks are set to kick off earnings season next week, with the XLF touching all-time highs. Goldman Sachs leads global dealmaking, capturing significant market share amid a rise in high-value mergers.

- **Labor Market Insights**: Upcoming labor reports indicate a slight drop in job openings, while ADP employment growth was below expectations, suggesting that the labor market may not exert inflationary pressure moving forward.

---

## Upcoming Portfolio Earnings (Next 2 Weeks)

### Thursday, January 08

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **LNN** | | Before Open | $1.46 | $167M |
| **SLP** | | Before Open | $0.18 | $18M |
| **AEHR** | | After Close | $-0.08 | $12M |

### Tuesday, January 13

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **JPM** | | Before Open | $4.97 | $46.0B |

### Wednesday, January 14

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **WFC** | | Before Open | $1.65 | $21.6B |
| **C** | | Before Open | $1.72 | $20.7B |

### Thursday, January 15

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **TSM** | | Before Open | $2.72 | $1019.3B |
| **BLK** | | Before Open | $12.55 | $6.8B |
| **JBHT** | | Before Open | $1.77 | $3.1B |

### Tuesday, January 20

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **SCHW** | | Before Open | $1.32 | $6.2B |
| **NFLX** | | After Close | $0.55 | - |

### Wednesday, January 21

| Ticker | Company | Time | EPS Est. | Revenue Est. |
|:-------|:--------|:----:|--------:|-------------:|
| **JNJ** | | Before Open | $2.53 | $24.1B |

---

## US Economic Calendar

| Time | Event | Actual | Estimate | Previous |
|:-----|:------|-------:|---------:|---------:|
| TBD | MBA Mortgage Applications (Jan/02) | 0.3 | None | -10 |
| TBD | MBA 30-Year Mortgage Rate (Dec/26) | 6.32 | None | 6.31 |
| TBD | MBA Mortgage Market Index (Dec/26) | 269.9 | None | 299.8 |
| TBD | MBA Mortgage Applications (Dec/26) | -10 | None | -5 |
| TBD | MBA 30-Year Mortgage Rate (Jan/02) | 6.25 | None | 6.32 |
| TBD | MBA Mortgage Market Index (Jan/02) | 270.8 | None | 269.9 |
| TBD | MBA Mortgage Refinance Index (Dec/26) | 872.1 | None | 1084.3 |
| TBD | MBA Mortgage Refinance Index (Jan/02) | 937 | None | 872.1 |
| TBD | MBA Purchase Index (Dec/26) | 169.8 | None | 169.9 |
| TBD | MBA Purchase Index (Jan/02) | 159.3 | None | 169.8 |
| TBD | ADP Employment Change (Dec) | 41 | 47 | -32 |
| TBD | ISM Non-Manufacturing Employment (Dec) | None | None | 48.9 |
| TBD | Durable Goods Orders Ex Defense MoM | None | -1.5 | -1.5 |
| TBD | Durable Goods Orders Ex Transp MoM | None | None | 0.2 |
| TBD | Factory Orders ex Transportation (Nov) | None | 0.3 | None |
| TBD | Factory Orders ex Transportation (Oct) | None | -0.3 | 0.2 |
| TBD | Factory Orders MoM (Nov) | None | 0.4 | None |
| TBD | Factory Orders MoM (Oct) | None | -1.2 | 0.2 |
| TBD | JOLTs Job Quits (Nov) | None | 2.99 | 2.941 |
| TBD | JOLTs Job Openings (Nov) | None | 7.6 | 7.67 |
| TBD | ISM Services Prices (Dec) | None | 65.5 | 65.4 |
| TBD | ISM Services PMI (Dec) | None | 52.3 | 52.6 |
| TBD | ISM Services New Orders (Dec) | None | 52.2 | 52.9 |
| TBD | ISM Services Employment (Dec) | None | 48.7 | 48.9 |
| TBD | ISM Services Business Activity (Dec) | None | 54 | 54.5 |
| TBD | ISM Non-Manufacturing Prices (Dec) | None | None | 65.4 |
| TBD | ISM Non-Manufacturing PMI (Dec) | None | 52.2 | 52.6 |
| TBD | ISM Non-Manufacturing New Orders (Dec) | None | None | 52.9 |
| TBD | ISM Non-Manufacturing Business Activity (Dec) | None | None | 54.5 |
| TBD | EIA Weekly Refinery Utilization Rates WoW | None | None | 0.1 |
| TBD | EIA Refinery Crude Runs Change (Jan/02) | None | None | 0.071 |
| TBD | EIA Heating Oil Stocks Change (Jan/02) | None | None | 0.134 |
| TBD | Imports | None | None | -0.957 |
| TBD | EIA Gasoline Stocks Change (Jan/02) | None | 2.9 | 5.845 |
| TBD | EIA Gasoline Production Change (Jan/02) | None | None | -0.352 |
| TBD | EIA Distillate Stocks Change (Jan/02) | None | 2.2 | 4.977 |
| TBD | EIA Cushing Crude Oil Stocks Change (Jan/02) | None | None | 0.543 |
| TBD | EIA Distillate Fuel Production Change (Jan/02) | None | None | -0.076 |
| TBD | EIA Crude Oil Stocks Change (Jan/02) | None | 1.1 | -1.934 |
| TBD | EIA Crude Oil Imports Change (Jan/02) | None | None | -0.957 |
| TBD | 17-Week Bill Auction | None | None | None |
| TBD | CFTC Copper Speculative net positions | None | None | 67.1 |
| TBD | CFTC Aluminium Speculative net positions | None | None | -2.4 |
| TBD | CFTC Corn speculative net positions | None | None | 64.9 |
| TBD | CFTC Crude Oil speculative net positions | None | None | 64.9 |
| TBD | CFTC Gold Speculative net positions | None | None | 240.7 |
| TBD | CFTC Nasdaq 100 speculative net positions | None | None | 31.8 |
| TBD | CFTC Natural Gas speculative net positions | None | None | -156.3 |
| TBD | CFTC Silver Speculative net positions | None | None | 35.9 |
| TBD | CFTC Soybeans speculative net positions | None | None | 157.8 |
| TBD | CFTC S&P 500 speculative net positions | None | None | -81.8 |
| TBD | CFTC Wheat speculative net positions | None | None | -71.8 |
| TBD | Fed Bowman Speech | None | None | None |

---



*Generated on 2026-01-07 at 08:51:32*
